Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$209.01 - $232.56 $113,492 - $126,280
-543 Reduced 8.32%
5,981 $1.31 Million
Q4 2023

Feb 07, 2024

BUY
$197.69 - $227.29 $1.29 Million - $1.48 Million
6,524 New
6,524 $1.48 Million
Q2 2023

Aug 07, 2023

BUY
$211.93 - $241.33 $30,305 - $34,510
143 Added 8.13%
1,901 $458,000
Q1 2023

May 05, 2023

BUY
$213.32 - $257.83 $143,564 - $173,519
673 Added 62.03%
1,758 $403,000
Q4 2022

Jan 30, 2023

BUY
$203.72 - $248.97 $221,036 - $270,132
1,085 New
1,085 $255,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.